chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, aches and pains, headache, fatigue (very pronounced on the second day) Aches and pains are in same place where Rheumatoid Arthritis aches and pains usually come.
AE start date update (lump); AE start date update (rash); AE start date update (pain); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (AE start date update (lump)), VACCINATION SITE RASH (AE start date update (rash)) and VACCINATION SITE PAIN (AE start date update (pain)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE MASS (AE start date update (lump)), VACCINATION SITE RASH (AE start date update (rash)) and VACCINATION SITE PAIN (AE start date update (pain)). At the time of the report, VACCINATION SITE MASS (AE start date update (lump)), VACCINATION SITE RASH (AE start date update (rash)) and VACCINATION SITE PAIN (AE start date update (pain)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
There was some pain at the injection site almost immediately; It remained painful for several days. A red area developed around the injection site - approximately 5 inches by 3 inches and the skin was warm with a slight welting. More importantly, during the 12 hours immediately following the injection, my entire body ached - every muscle seemed to be affected and I was very tired. I felt feverish; however, I did not measure a temperature. I took three ibuprofen to relieve the muscle ache. I had several matters to accomplish during the day immediately following the vaccination, which I did manage to complete, albeit not up to par. The muscle ache resolved within 24-48 hours.
Received her H1N1 vaccination (injection) on 3Feb10 and within minutes began to experience "itchiness" in her throat. She then began to experience chest tightness so she took oral BENADRYL 25mg. After 20 minutes the pt proceeded to local BMC for evaluation. The clinic provider documented that the patient "does have a pork allergy for which she experiences the exact symptoms. (+) throat tightening sensation (+) chest tightness (+) palpitations (+) tingling of lips and B/L fingertips. The pt who was initially tachycardic and tachypneic although having normal/stable BP and SpO2, remained in the clinic for 2 hours during which all her symptoms, after her original BENADRYL and without further treatment, resolved. Throughout her observation period, she was without evidence of hypoxia, stridor, wheezing, N/V/D, lightheadedness, urticaria, angioedema, or other sx to suggest anaphylaxis. She has no history of prior adverse reactions to vaccinations.
within 2 minutes of vaccine strong heart palpatations with elevated blood pressure; waited and observed by staff for 30 minutes; these first symptoms resolved in 30 minutes;  all night of the vaccination increased adrenaline rushes throughout whole body; 2 days after vaccination  and continued for a week: red bumpy rash on right side of neck which spread lightly to below neck within hours; intense belly pain of lower abdomen; bloating on all liquid/food consumption; extremely fatigued;
Patient called 11-18-15 complaining that was breaking out, itching, and sores on feet and fingers.
Pt got flu at 8:30am, then about 10:30, report from staff stating pt fainting in halls.  PT had asked for Tylenol prior to shot.  Pt seem lethargic, sweaty, clamming, somewhat hesitant to respond.  BP 180/100, temperature: 97.4, pulse: 72, respiratory: 24.  BS/2T.  PT sent to health care for evaluation.  Later sent to ER for high blood pressure, then discharged home about 15:00.
1-2 minute tonic clonic generalized episode about 3 hrs p/shots;
Patient reported left arm was burning within 10 minutes of receiving vaccine. Visible redness observed around injection site. Healthcare providers monitored closely -- noted left arm with developing rash, increasing warmth to touch, redness / rash on left upper arm spreading to neck and chest. Patient reported scratchy throat, onset of throat tightness and difficulty swallowing. EPI Pen administered in left thigh at 1128am. EMS activated. Patient remained awake and alert.  EMS arrived at 1139am, transported patient to ER via stretcher. Patient released from ER same day.
On 2/12/21, Pt had Moderna vaccine at 12:12, was advised to stay 30 min until 12:42 due to allergy to contrast dye (several medications were given in hospital on previous occassion); at 12:26 patient c/o headache to back of head, traveling toward front of head with an odd feeling on her tongue; no visual swelling observed. Pt was given Benadryl liquid 50 mg x 1 at 12:28. Patient expressed relief of tongue symptoms at 12:35, stayed until 12:45. Checked with patient twice, family aware she was on her way home; she was alert, expressing no disability, when she left the building.
?COVID arm? - rash appeared on site of injection approximately 7 days after the first dose of Moderna. It is not itchy or painful, just a large slightly elevated red mark on my upper arm. It is still currently present (7 hours later). No other symptoms or side effects.
Vivid dreams; This spontaneous case was reported by an other health care professional and describes the occurrence of ABNORMAL DREAMS (Vivid dreams) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. en6199) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    The patient's past medical history included Psoriatic arthritis since July 2007, Thyroid neoplasm malignant since an unknown date, Vivid dreams and Psoriasis since an unknown date. Concurrent medical conditions included Allergy (Sulfonamide allergy).   In July 2007, the patient started ADALIMUMAB (HUMIRA) (unknown route) 40 mg. On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. In June 2021, the patient experienced ABNORMAL DREAMS (Vivid dreams). At the time of the report, ABNORMAL DREAMS (Vivid dreams) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Blood test: Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant Drugs Not Reported.   Reporter did not allow further contact
Patient given a DT rather than DTaP as ordered. No adverse reaction, however, patient will be given an additional dose of DTaP to ensure pertussis coverage.
pt recvd vax @ 2 wks gestation; & JUN94 delivered healthy newborn male; there were no problems w/pregnancy or labor; It was noted that the pt had a small growth on ear which was present @ birth; No further details were provided;
little lightheaded; his balance worsened after the vaccines; his blood sugars dropped below 150 after a week. At the end of the week, his blood sugars went back up a little and now continue to range from 50 (lowest) to 150; injection site was itchy but not red; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little lightheaded), BALANCE DISORDER (his balance worsened after the vaccines), BLOOD GLUCOSE FLUCTUATION (his blood sugars dropped below 150 after a week. At the end of the week, his blood sugars went back up a little and now continue to range from 50 (lowest) to 150) and VACCINATION SITE PRURITUS (injection site was itchy but not red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Asperger's syndrome. Concomitant products included INSULIN for Diabetes.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little lightheaded), BALANCE DISORDER (his balance worsened after the vaccines), BLOOD GLUCOSE FLUCTUATION (his blood sugars dropped below 150 after a week. At the end of the week, his blood sugars went back up a little and now continue to range from 50 (lowest) to 150) and VACCINATION SITE PRURITUS (injection site was itchy but not red). At the time of the report, DIZZINESS (little lightheaded) and BALANCE DISORDER (his balance worsened after the vaccines) had resolved and BLOOD GLUCOSE FLUCTUATION (his blood sugars dropped below 150 after a week. At the end of the week, his blood sugars went back up a little and now continue to range from 50 (lowest) to 150) and VACCINATION SITE PRURITUS (injection site was itchy but not red) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 350-450 (High) blood sugar high had been in 350-450, 200 (Low) low around 200, below 150 (abnormal) his blood sugars dropped below 150 after a week. and 50-150 (abnormal) blood sugars went back up a little and now continue to range from 50 (lowest) to 150.         Concomitant include patient stated he went from taking 4 shots of insulin (unspecified) a day. and he advised & takes 1 shot of insulin a day of long-lasting insulin Flex touch at 35 units daily and is no longer on the Novolin FlexPen.  No treatment information was provided.  Patient stated He started controlling is diet more and eating keto type foods especially snacks. Consumer stated his sugars were coming down some, "but it was still stubborn" And stated his blood sugars have stayed even.   This case was linked to MOD-2021-320975 (Patient Link).
A male.  Admitted from the ER for chest pain, nausea & vomiting.  Patient had ST elevation myocardial infarction.  Hx. of CAD, Diabetes, hypertention & medical non-compliance.  Discharged home on 5/1/22.
After receiving her third dose of GARDASIL approx. 30 seconds after vaccine, patient had a syncopal episode. Patient fell off exam table hitting her head - LOC approx 30 sec. Pt. was examined by doctor & ice applied to head & observed for 30 min.
Patient stated that she went home after vaccination and after about 2 hours she got red in the face head was spinning, and was walking sideways.  She suffered a seizure and was hospitalized for 1 week.
high fever stated by mom;mom did not take temp;hallucinations from 1:00-5:30AM (saw snakes & worms);APAP;t101;
Immunization given at 2:10pm on 11/13/18. On 11/14/18 at 9:30 am, patient's husband contacted the pharmacy and talked to the pharmacist. He stated that overnight she woke up and got up and fainted. She is fine now, other than feeling a little weak.
Experienced a sensation of ears feeling plugged and some hearing loss.  Hearing affected and unresolved 2 days later.
SPINE WAS IN PAIN; HER BACK FELT EXTREMELY STIFF; CHILLS; HIGH FEVER; EXTREME FATIGUE; BODY FEELS WEAK; LOW GRADE FEVER ON AND OFF; This spontaneous report received from a patient concerned a 20 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-JUL-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 08-JUL-2021, the subject experienced extreme fatigue. On 08-JUL-2021, the subject experienced body feels weak. On 08-JUL-2021, the subject experienced low grade fever on and off. Laboratory data included: Body temperature (NR: not provided) 99.7-101.5 Fahrenheit. On an unspecified date, the subject experienced spine was in pain, her back felt extremely stiff, chills, and high fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from spine was in pain, her back felt extremely stiff, chills, and high fever, and had not recovered from extreme fatigue, body feels weak, and low grade fever on and off. This report was non-serious.
Very ill with High Fever over 103 - could not get out of bed for one full day.  Bad stomach ache on left side, headache.  Freezing, shivering..
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 59-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included TETANUS VACCINE for prophylaxis. On 3rd July 2018, the patient received the 1st dose of SHINGRIX and TETANUS VACCINE. On 3rd July 2018, less than a day after receiving SHINGRIX and TETANUS VACCINE, the patient experienced pruritus. On 4th July 2018, the patient experienced shingles. On an unknown date, the outcome of the shingles and pruritus were recovering/resolving. It was unknown if the reporter considered the shingles and pruritus to be related to SHINGRIX. Additional details were provided as follows:  The age at the vaccination was not reported. The patient was administered SHINGRIX in the left arm and Tetanus vaccine in the right arm. It was suggested that he get the shot for Shingles. After further review of his chart, the pharmacist knew that he was overdue for the tetanus shot, so the patient took both vaccines at the same time.  The patient said it started with the itching and then the breakout from shingles.   The patient stated that the next day after getting the vaccines, that he noticed that he was experiencing signs of shingles. The patient said that there was a straight line on the back of his calves on both legs and left hamstring. The patient has had shingles before so he knew what he was talking about. The line from the shingles was about three inches wide and half inch line.   The lines were very itchy but it was getting better at the time of reporting. The patient did report it to his physician who suggested him to try anti itching lotion to treat the itching until it, shingles cleared up. The symptoms were resolving themselves. The patient said it was more of a nuisance than anything. The patient stated that he would not be getting the second dose of the vaccine.
Flu-like symptoms, chills, muscle aches, fever 100.9, and diarrhea
FEVER; HANGOVER-LIKE HEADACHES; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 2021, the subject experienced fever. On 2021, the subject experienced hangover-like headaches. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and hangover-like headaches on 2021. This report was non-serious.
Patient felt mildly short of breath and fatigued about 30 minutes after receiving the vaccine.  Patient had returned to immunization area after walking around the store and was given 25mg diphenhydramine liquid.  Patient rested another 10 minutes and said he felt better.
pt recvd vax;devel mottling of skin 1-2 hrs p/ vax,accompanied by grunting,lethargy,fever of 101.5;had sz approx 10 hrs p/vax,poss febrile sz;in ofc given epi & sent to er;was adm,recvd rocephin p/ septic work up;
1:55pm Pt. complains about chest pain rate 5 in scale (1-10).  Vital sighs show:  BP 109/48, SAT 99%, P 79 and ECG (sinus rhythm).  Mother of the pt. refuse take pt. to the hospital after pt. verbalized feel no chest pain few minutes after the assessment.  Pt. has allergy to penicillin (no airway).
Ophthalmology consult was subsequently obtained with diagnosis of acute optic neuritis. First dose of Pfizer Covid vaccine on 4/22/2021 with onset of symptoms approximately 2 to 3 weeks thereafter. Bilateral vision loss 2/2 optic neuritis that is new. Initially involving only the right eye, transient improvement with Solu-Medrol approximately 1 month prior to admission, but with recurrence and later with development of vision loss in the left eye as well for approximately 1 week prior to admission. Unclear etiology.  MS felt less likely with negative oligoclonal bands, NMO antibody negative, though per neuro, still potential for neuromyelitis optica, MOG 1:40.  Also consideration that may be a complication of having received COVID-19 vaccine, though relationship remains unclear. 2-3 weeks prior to symptoms patient received vaccine. Short time after was also diagnosed with Mono and UTI. Got IV methylprednisolone of 1 g daily x4 doses without significant improvement.   Then required total plasma exchange over 2 weeks, resulted in mild symptom improvement. CDC reports optic neuritis may be related to vaccinations in general (52.4% of cases within 8 weeks of vaccination). No evidence for COVID vaccines at this time. Added Pfizer vaccine to allergy list per neuro recommendations.
erythema, ecchymosis, pain & edema @ inject site are reported in a pt receiving 1 dose of flu vax; above sx occurred 12 hrs p/flu vax & resolved w/in 48 hrs;
cataract; This is a spontaneous report from a contactable consumer (patient) via a  sponsored program. This 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left upper arm on 26Mar2021 09:30 (at the age of 59-year-old) as single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. She was not enrolled in the clinical trial. Medical history included ongoing diabetes mellitus for 2 years (2019), heart attack occurred 6 years ago (2015), and she has had the following conditions for probably about 5 or 6 years: ongoing blood cholesterol increased, ongoing blood potassium decreased, ongoing heartburn, and ongoing high blood pressure. Family Medical History included her mom died of cancer and her dad died of a massive heart attack. Concomitant medications included metformin (manufacturer unknown) taken for diabetes mellitus, metoprolol (manufacturer unknown) taken for heart attack, ezetimibe (manufacturer unknown) taken for blood cholesterol, prasugrel hydrochloride (EFFIENT) taken for stent placement, losartan (manufacturer unknown) taken for hypertension, potassium chloride (manufacturer unknown) taken for blood potassium decreased, omeprazole (PROTONIX) taken for heartburn; all ongoing from an unspecified start date. On an unspecified date in 2021, the patient developed cataract. As reported, the patient just had her eye cataracts removed, one at a time: she had one done 05Apr2021 for the left eye, and one done yesterday, 19Apr2021 for the right one. She had a scheduled second dose due last 16Apr2021, but she missed it, so she was asking how to re-schedule the second dose. The clinical outcome of the cataract was not reported.
Information has been received from a pharmacist concerning a female with shellfish allergy and latex allergy who on unspecified dates was vaccinated with the first and second doses of PNEUMOVAX 23. There was no concomitant medication. The patient developed swelling and redness at the injection site as well as dyspnea, after receiving her second dose of PNEUMOVAX 23. The patient was evaluated and treated at a local emergency room but details are not available. On an unspecified date, the patient fully recovered. Additional information has been requested.
Client had a J&J vaccine at 1327. He reported that he was having trouble breathing around 1333. He reported that he felt hot and sweaty and lightheaded. He appeared distressed. We called 911, then we provided a client with a cold pack. His pulse was 47 bpm and his spO2 was 97%. He continued to state that he was lightheaded so we had him lay down on the ground and take deep breaths. EMS arrived they collected his vitals which were WNL. His blood glucose was 71. He was warm and moist to the touch. EMS stayed with the client until 1350 at which point he had sat up and sat in the chair. He said he was definitely not having trouble breathing anymore and was feeling better. Provided client with a juice box and water. Client stayed onsite until 1410 at which point he said he felt comfortable leaving.  Client walked unassisted out of the clinic.
? Patient filled out first dose PFIZER vaccine consent paperwork, and marked ?yes? and ?Johnson & Johnson? for Question #3 ?Have you ever received a dose of COVID-19 vaccine?? ? The vaccinating nurse asked the patient to clarify if they have every had a COVID-19 vaccine before. Per Nurse, the patient stated they had NOT had any doses of COVID-19 prior. ? Patient was then vaccinated with 0.3mL of  PFIZER COVID-19 vaccine LOT EW0168, in the Left Deltoid.  ? Upon searching for patient in registry, a search  result of the patient?s name and birthday resulted in a similar name with the same birthday. The only difference is that the patient consent form has the middle name spelled out on it, the registry record only lists the first initial of the middle name (but it matches).  ? The patient info in registry states that the patient was vaccinated on March 3, 2021 with 0.5mL of Johnson & Johnson COVID-19 vaccine Lot 1805020. ?  Public Health was contacted and consent from March 3rd dose was faxed to Public Health. Confirmed it was the same patient passed on First, Last, DOB, address, phone number and email. ? Patient was contacted and informed of event
awoke w/disorientation, headache, T103.5;disoriented, stiff neck, chills, fatigue;dx w/mono 10/10/99;
R deltoid muscle soreness - worse with abduction of shoulder Follow-up: Patient stated "soreness started ever since she got the flu shot. Soreness when she bends her arm. Injection given 12/10/09.